UnitedHealth Group Incorporated is rated a Strong Buy with a $400 price target, reflecting 19% upside. Learn more about UNH ...

The health insurance giant's stock got a big boost after Wall Street learned Berkshire Hathaway had invested in it.

UNH trades below its five-year median P/E as it navigates margin pressure, membership declines and strategic divestments.

Discover why UnitedHealth Group (UNH) is rated Buy, with margin recovery, earnings growth, and 154% upside potential.

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...

UnitedHealth Group (UNH) has quietly clawed back some recent losses, with the stock up around 5% over the past 3 months even ...

Palantir's valuation is far above what investors witnessed at the peak of the dot-com bubble. UnitedHealth stock sold off earlier this year amid some operational headwinds. Warren Buffett bought the ...

UnitedHealth Group (UNH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Thinking about whether UnitedHealth Group is a bargain or just another blue-chip to watch? You are not alone, as many ...

The potential gap between the Upside and Downside scenarios for UNH in 2026 exceeds an extraordinary $400+ per share, ...

Here's why Oscar Health may be the ultimate value stock to buy for 2026's economic shift, even though it is not profitable ...